This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Eye Allergies
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to compare patient satisfaction with Pataday (Olopatadine hydrochloride 0.2%) one daily (QD) and Bepreve (Bepotastine besilate ophthalmic solution 1.5%) two times a day (BID).

Provided treatments

  • Drug: Olopatadine hydrochloride 0.2%
  • Drug: Bepotastine besilate ophthalmic solution 1.5%

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01450176. The sponsor of the trial is McCabe Vision Center and it is looking for 30 volunteers for the current phase.
Official trial title:
Comparing Patient Satisfaction Throughout the Day With PATADAY (OLOPATADINE HYDROCHLORIDE) 0.2% QD or BEPREVE (BEPOTASTINE BESILATE OPHTHALMIC SOLUTION) 1.5% BID